CN1189168A - Hydrophobic heteroatom-containing sequestrant for cholesterol depletion - Google Patents
Hydrophobic heteroatom-containing sequestrant for cholesterol depletion Download PDFInfo
- Publication number
- CN1189168A CN1189168A CN96194613A CN96194613A CN1189168A CN 1189168 A CN1189168 A CN 1189168A CN 96194613 A CN96194613 A CN 96194613A CN 96194613 A CN96194613 A CN 96194613A CN 1189168 A CN1189168 A CN 1189168A
- Authority
- CN
- China
- Prior art keywords
- polymer
- carbon atoms
- allylamine
- amine
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002209 hydrophobic effect Effects 0.000 title claims abstract description 64
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims description 20
- 239000003352 sequestering agent Substances 0.000 title abstract description 4
- 235000012000 cholesterol Nutrition 0.000 title description 4
- 125000005842 heteroatom Chemical group 0.000 title description 2
- 229920000642 polymer Polymers 0.000 claims abstract description 218
- 150000001412 amines Chemical group 0.000 claims abstract description 147
- 229920000083 poly(allylamine) Polymers 0.000 claims abstract description 126
- 125000001424 substituent group Chemical group 0.000 claims abstract description 100
- -1 poly(allylamine) Polymers 0.000 claims abstract description 67
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 56
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 56
- 238000000034 method Methods 0.000 claims abstract description 50
- 241000124008 Mammalia Species 0.000 claims abstract description 34
- 150000003512 tertiary amines Chemical class 0.000 claims abstract description 9
- 239000003833 bile salt Substances 0.000 claims abstract description 6
- 229940093761 bile salts Drugs 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 118
- 125000004432 carbon atom Chemical group C* 0.000 claims description 113
- 125000002947 alkylene group Chemical group 0.000 claims description 50
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 47
- 150000001875 compounds Chemical class 0.000 claims description 32
- 229910052757 nitrogen Inorganic materials 0.000 claims description 21
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 20
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 20
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 20
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 17
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- 230000001225 therapeutic effect Effects 0.000 claims description 14
- 239000000460 chlorine Substances 0.000 claims description 13
- 229910052801 chlorine Inorganic materials 0.000 claims description 13
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 13
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 claims description 6
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 201000001320 Atherosclerosis Diseases 0.000 claims description 4
- 208000035150 Hypercholesterolemia Diseases 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims 3
- 239000002168 alkylating agent Substances 0.000 abstract description 37
- 229940100198 alkylating agent Drugs 0.000 abstract description 37
- 239000003613 bile acid Substances 0.000 abstract description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 99
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 72
- 239000007787 solid Substances 0.000 description 59
- 239000000243 solution Substances 0.000 description 44
- 238000006243 chemical reaction Methods 0.000 description 36
- 238000003756 stirring Methods 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 238000005804 alkylation reaction Methods 0.000 description 32
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 30
- 230000029936 alkylation Effects 0.000 description 30
- 239000000203 mixture Substances 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 239000008367 deionised water Substances 0.000 description 21
- 229910021641 deionized water Inorganic materials 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 21
- FCQSEXGTTIULLO-UHFFFAOYSA-M 3-chloropropyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCl FCQSEXGTTIULLO-UHFFFAOYSA-M 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 239000000178 monomer Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 239000011780 sodium chloride Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 12
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 238000002390 rotary evaporation Methods 0.000 description 12
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000002738 chelating agent Substances 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- YWWLWXAGAFDLHC-UHFFFAOYSA-M 3-bromopropyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCBr YWWLWXAGAFDLHC-UHFFFAOYSA-M 0.000 description 9
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 9
- 239000003431 cross linking reagent Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- 229960004132 diethyl ether Drugs 0.000 description 8
- YWFWDNVOPHGWMX-UHFFFAOYSA-N n,n-dimethyldodecan-1-amine Chemical compound CCCCCCCCCCCCN(C)C YWFWDNVOPHGWMX-UHFFFAOYSA-N 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 239000012265 solid product Substances 0.000 description 7
- 238000003828 vacuum filtration Methods 0.000 description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 229920001577 copolymer Chemical compound 0.000 description 6
- 229920001519 homopolymer Polymers 0.000 description 6
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 5
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 5
- ACYWYYRQTAEQFS-UHFFFAOYSA-M 4-chlorobutyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCCl ACYWYYRQTAEQFS-UHFFFAOYSA-M 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000009103 reabsorption Effects 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- XCDVWZJDGLZKBZ-UHFFFAOYSA-M 3-chloropropyl-decyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCl XCDVWZJDGLZKBZ-UHFFFAOYSA-M 0.000 description 4
- PPTXCAJGJJOOHG-UHFFFAOYSA-M 3-chloropropyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCl PPTXCAJGJJOOHG-UHFFFAOYSA-M 0.000 description 4
- AANXHXIUHZYWHJ-UHFFFAOYSA-M 3-chloropropyl-dimethyl-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CCCCl AANXHXIUHZYWHJ-UHFFFAOYSA-M 0.000 description 4
- QVIYYENQXNJSRK-UHFFFAOYSA-M 3-chloropropyl-hexyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCC[N+](C)(C)CCCCl QVIYYENQXNJSRK-UHFFFAOYSA-M 0.000 description 4
- NOCABFCXUWNCKW-UHFFFAOYSA-M 3-chloropropyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCl)CCCCCCCC NOCABFCXUWNCKW-UHFFFAOYSA-M 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- YJLYANLCNIKXMG-UHFFFAOYSA-N N-Methyldioctylamine Chemical compound CCCCCCCCN(C)CCCCCCCC YJLYANLCNIKXMG-UHFFFAOYSA-N 0.000 description 4
- 239000003858 bile acid conjugate Substances 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 3
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 3
- YPBPBWZBMWLNLX-UHFFFAOYSA-M 2-chloroethyl-dodecyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCl YPBPBWZBMWLNLX-UHFFFAOYSA-M 0.000 description 3
- KNWRUFVCYKUGQO-UHFFFAOYSA-M 3-chloropropyl-cyclohexyl-dimethylazanium;bromide Chemical compound [Br-].ClCCC[N+](C)(C)C1CCCCC1 KNWRUFVCYKUGQO-UHFFFAOYSA-M 0.000 description 3
- AHJQLIZGHOSLOZ-UHFFFAOYSA-M 4-chlorobutyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCCl)CCCCCCCC AHJQLIZGHOSLOZ-UHFFFAOYSA-M 0.000 description 3
- BUBUZBFBYKUKMK-UHFFFAOYSA-M 6-bromohexyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCCCCBr BUBUZBFBYKUKMK-UHFFFAOYSA-M 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- 239000004380 Cholic acid Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 3
- 235000019416 cholic acid Nutrition 0.000 description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 description 2
- VEAFAIWDEKMSMR-UHFFFAOYSA-M 10-bromodecyl(trimethyl)azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCCCCCCBr VEAFAIWDEKMSMR-UHFFFAOYSA-M 0.000 description 2
- NCCQZSRARYTGHW-UHFFFAOYSA-M 3-chloropropyl-didecyl-methylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(CCCCl)CCCCCCCCCC NCCQZSRARYTGHW-UHFFFAOYSA-M 0.000 description 2
- WZKCTAJFWYZCBW-UHFFFAOYSA-M 3-chloropropyl-dimethyl-octadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCl WZKCTAJFWYZCBW-UHFFFAOYSA-M 0.000 description 2
- FHQFIPVLPMRBBR-UHFFFAOYSA-M 4-bromobutyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCCCBr)CCCCCCCC FHQFIPVLPMRBBR-UHFFFAOYSA-M 0.000 description 2
- MKFDDLPPSMYYQU-UHFFFAOYSA-N 5-chloropentyl-dodecyl-methylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[NH+](C)CCCCCCl MKFDDLPPSMYYQU-UHFFFAOYSA-N 0.000 description 2
- XCEXUPHOWRJNOR-UHFFFAOYSA-M 6-chlorohexyl-decyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCl XCEXUPHOWRJNOR-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 150000004820 halides Chemical group 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- UQKAOOAFEFCDGT-UHFFFAOYSA-N n,n-dimethyloctan-1-amine Chemical compound CCCCCCCCN(C)C UQKAOOAFEFCDGT-UHFFFAOYSA-N 0.000 description 2
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- WAVDSLLYAQBITE-UHFFFAOYSA-N (4-ethenylphenyl)methanamine Chemical compound NCC1=CC=C(C=C)C=C1 WAVDSLLYAQBITE-UHFFFAOYSA-N 0.000 description 1
- GTQHJCOHNAFHRE-UHFFFAOYSA-N 1,10-dibromodecane Chemical compound BrCCCCCCCCCCBr GTQHJCOHNAFHRE-UHFFFAOYSA-N 0.000 description 1
- IFPMZBBHBZQTOV-UHFFFAOYSA-N 1,3,5-trinitro-2-(2,4,6-trinitrophenyl)-4-[2,4,6-trinitro-3-(2,4,6-trinitrophenyl)phenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C=2C(=C(C=3C(=CC(=CC=3[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=CC=2[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)=C1[N+]([O-])=O IFPMZBBHBZQTOV-UHFFFAOYSA-N 0.000 description 1
- YHRUOJUYPBUZOS-UHFFFAOYSA-N 1,3-dichloropropane Chemical group ClCCCCl YHRUOJUYPBUZOS-UHFFFAOYSA-N 0.000 description 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- SGRHVVLXEBNBDV-UHFFFAOYSA-N 1,6-dibromohexane Chemical compound BrCCCCCCBr SGRHVVLXEBNBDV-UHFFFAOYSA-N 0.000 description 1
- OQILSTRGJVCFAG-UHFFFAOYSA-N 1-(oxiran-2-ylmethoxy)butan-1-ol Chemical compound CCCC(O)OCC1CO1 OQILSTRGJVCFAG-UHFFFAOYSA-N 0.000 description 1
- PHHNNDKXQVKJEP-UHFFFAOYSA-N 1-bromo-5-chloropentane Chemical compound ClCCCCCBr PHHNNDKXQVKJEP-UHFFFAOYSA-N 0.000 description 1
- RRMRPTOMFGARDV-UHFFFAOYSA-M 12-bromododecyl-decyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCBr RRMRPTOMFGARDV-UHFFFAOYSA-M 0.000 description 1
- CUGZWHZWSVUSBE-UHFFFAOYSA-N 2-(oxiran-2-ylmethoxy)ethanol Chemical compound OCCOCC1CO1 CUGZWHZWSVUSBE-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- OTKLRHWBZHQJOP-UHFFFAOYSA-N 3-aminopropyl prop-2-enoate Chemical compound NCCCOC(=O)C=C OTKLRHWBZHQJOP-UHFFFAOYSA-N 0.000 description 1
- UVKTWFDHGDPIGF-UHFFFAOYSA-N 3-bromopropyl(tridecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCC[NH2+]CCCBr UVKTWFDHGDPIGF-UHFFFAOYSA-N 0.000 description 1
- RYNNSZKWDKFHCL-UHFFFAOYSA-M 3-bromopropyl-dimethyl-octylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(C)CCCBr RYNNSZKWDKFHCL-UHFFFAOYSA-M 0.000 description 1
- MANIVFOGNGPSKT-UHFFFAOYSA-M 3-bromopropyl-docosyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCBr MANIVFOGNGPSKT-UHFFFAOYSA-M 0.000 description 1
- YDTKSGCVOOXIIQ-UHFFFAOYSA-M 3-chloropropyl-dodecyl-diethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](CC)(CC)CCCCl YDTKSGCVOOXIIQ-UHFFFAOYSA-M 0.000 description 1
- ZEANSETUBDDANL-UHFFFAOYSA-M 3-iodobutyl-methyl-dioctylazanium;bromide Chemical compound [Br-].CCCCCCCC[N+](C)(CCC(C)I)CCCCCCCC ZEANSETUBDDANL-UHFFFAOYSA-M 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- BYQRLLPYDSJZCP-UHFFFAOYSA-M 6-bromohexyl-docosyl-dimethylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCBr BYQRLLPYDSJZCP-UHFFFAOYSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- MUXOBHXGJLMRAB-UHFFFAOYSA-N Dimethyl succinate Chemical compound COC(=O)CCC(=O)OC MUXOBHXGJLMRAB-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- YBVRGFHWCCWTFG-UHFFFAOYSA-M [Br-].C(CCC)[N+](C)(CCCCCCCC)CCCCCCCC Chemical compound [Br-].C(CCC)[N+](C)(CCCCCCCC)CCCCCCCC YBVRGFHWCCWTFG-UHFFFAOYSA-M 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229920000080 bile acid sequestrant Polymers 0.000 description 1
- 229940096699 bile acid sequestrants Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 description 1
- SGTQHNNXGWOCBN-UHFFFAOYSA-M butyl-methyl-dioctylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCC)CCCCCCCC SGTQHNNXGWOCBN-UHFFFAOYSA-M 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 229960003340 calcium silicate Drugs 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- CQHUKEWNBNLJFA-UHFFFAOYSA-M cyclohexyl-dimethyl-propylazanium bromide Chemical compound [Br-].CCC[N+](C)(C)C1CCCCC1 CQHUKEWNBNLJFA-UHFFFAOYSA-M 0.000 description 1
- AAQUAAOHFUYIMI-UHFFFAOYSA-M decyl-dimethyl-(oxiran-2-ylmethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CC1CO1 AAQUAAOHFUYIMI-UHFFFAOYSA-M 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- NAPSCFZYZVSQHF-UHFFFAOYSA-N dimantine Chemical compound CCCCCCCCCCCCCCCCCCN(C)C NAPSCFZYZVSQHF-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VZXFEELLBDNLAL-UHFFFAOYSA-N dodecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCC[NH3+] VZXFEELLBDNLAL-UHFFFAOYSA-N 0.000 description 1
- UBOHYCDBALEWJC-UHFFFAOYSA-M dodecyl-dimethyl-[5-(4-methylphenyl)sulfonylpentyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCCCS(=O)(=O)C1=CC=C(C)C=C1 UBOHYCDBALEWJC-UHFFFAOYSA-M 0.000 description 1
- HSTNMAHVBABHLU-UHFFFAOYSA-M dodecyl-dimethyl-propylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCC HSTNMAHVBABHLU-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- MLCJWRIUYXIWNU-UHFFFAOYSA-N ethene-1,2-diamine Chemical group NC=CN MLCJWRIUYXIWNU-UHFFFAOYSA-N 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 229940099347 glycocholic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 210000003692 ilium Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 1
- QMHNQZGXPNCMCO-UHFFFAOYSA-N n,n-dimethylhexan-1-amine Chemical compound CCCCCCN(C)C QMHNQZGXPNCMCO-UHFFFAOYSA-N 0.000 description 1
- SFBHPFQSSDCYSL-UHFFFAOYSA-N n,n-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN(C)C SFBHPFQSSDCYSL-UHFFFAOYSA-N 0.000 description 1
- ATBNMWWDBWBAHM-UHFFFAOYSA-N n-decyl-n-methyldecan-1-amine Chemical compound CCCCCCCCCCN(C)CCCCCCCCCC ATBNMWWDBWBAHM-UHFFFAOYSA-N 0.000 description 1
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 1
- FFJMLWSZNCJCSZ-UHFFFAOYSA-N n-methylmethanamine;hydrobromide Chemical compound Br.CNC FFJMLWSZNCJCSZ-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012058 sterile packaged powder Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
The present invention relates to a poly(allylamine) polymer and, more generally, a hydrocarbon amine polymer. Preferably, these polymers are crosslinked. The present invention also relates to methods of forming these polymers and methods for their use. Further, the present invention relates to alkylating agents that can be employed to form the polymers and to methods for forming the alkylating agents. Generally, the polymer sequestrant includes a substituent bound to an amine of the polymer. The substituent includes a quaternary amine-containing moiety having one, two or three terminal hydrophobic substituents. A method of preparing quaternary amine-containing alkylating agents includes reacting an unsymmetrical dihalide with a tertiary amine having at least one hydrophobic substituent. A method for binding bile salts of bile acids in a mammal includes orally administering to the mammal a therapeutically-effective amount of the polymer sequestrant.
Description
Related application of the invention
This application is a partial continuation of U.S. application No. 08/469,659 (App. No.: 6/1995), which is a partial continuation of U.S. application No. 08/258,431 (App. No.: 6/10/1994) and U.S. application No. 08/332,096 (App. No.: 10/31/1994), which are all incorporated herein by reference.
Background of the invention
Bile acid salts act as detergents to solubilize and thereby help digest fat in food. Bile acids are produced from cholesterol and, therefore, removal of bile acids will result in a decrease in cholesterol. After digestion bile acids are either (passively) absorbed in the jejunum or reabsorbed by active transport in the ilium. Bile acid that is not reabsorbed is lost.
Reabsorption of bile acids from the intestinal tract preserves lipoprotein cholesterol in the bloodstream. In contrast, blood cholesterol concentrations may be reduced due to reduced reabsorption of bile acids.
One method of reducing the amount of bile acid reabsorption is to orally administer a compound that is capable of conjugating bile acids without itself being absorbed. These chelated bile acids are eventually excreted.
However, many bile acid sequestrants do not bind conjugated primary bile acids, e.g., do not bind conjugated bile acids well to prevent reabsorption of a major portion. In addition, the volume of chelating agent that can be digested is limited. As a result, the efficiency of many chelators in lowering blood cholesterol levels is also limited.
Moreover, the synthesis of many chelating agents can also be limited by the reaction yield and expense of preparing suitable precursors. For example, alkylating agents used to effect polymer modification can be difficult to prepare. In addition, the ability of the alkylating agent to react with the polymer may also limit the efficiency of the resulting chelating agent.
Thus, there is a need for a chelating agent and a method that overcomes or minimizes the above-mentioned difficulties.
Summary of the invention
This invention relates to poly (allylamine) polymers and, more generally, to hydrocarbon amine polymers. These polymers are preferably crosslinked. The invention also relates to methods of making and using these polymers. In addition, the present invention relates to alkylating agents useful in the preparation of these polymers and to processes for preparing alkylating agents.
In one aspect, the poly (allylamine) polymer is crosslinked and contains substituents attached to the amine of the polymer. The substituents include quaternary amine-containing moieties wherein the nitrogen of the quaternary amine moiety is linked to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having 6 to about 24 carbon atoms, and the remaining terminal substituents are each independently an alkyl group having 1 to about 5 carbon atoms.
A method of making a crosslinked poly (allylamine) polymer comprising reacting a crosslinked poly (allylamine) with a quaternary amine-containing compound having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
In another aspect, the invention relates to a hydrocarbyl amine polymer having a substituent attached to the amine of the polymer, the substituent comprising a quaternary amine-containing moiety wherein the nitrogen of said quaternary amine moiety is attached to the amine of the polymer by an alkylene group having 3 or more carbon atoms, and wherein at least two of the three terminal substituents of the quaternary amine are hydrophobic alkyl groups having 6 to about 24 carbon atoms and the remaining one terminal substituent is an alkyl group having 1 to about 5 carbon atoms.
The process for preparing the crosslinked hydrocarbon amine polymer of the present invention comprises polymerizing the crosslinked hydrocarbon amine polymerA step of reacting with a quaternary ammonium compound having the following formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
The methods of using the poly (allylamine) polymers and hydrocarbon amine polymers of the invention include orally administering to a mammal a therapeutic amount of these polymers to bind bile acids, lower blood cholesterol, treat atherosclerosis, treat hypercholesterolemia, or lower blood lipid levels in a mammal. In another aspect, the present invention relates to quaternary ammonium compounds having the structure,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
A method of preparing a quaternary ammonium compound comprises reacting a tertiary amine having the formula:
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
a step of reacting with an asymmetric dihalide having the formula,
X1--(CH2)n--X2
wherein,
X1is a chlorine-containing compound having a chlorine-containing group,
X2is bromine, and
n is an integer of 3 or more.
The present invention has many advantages. For example, the poly (allylamine) and hydrocarbon amine polymer sequestrants of the present invention bind to conjugated bile acids, including primary bile acids, which would otherwise be actively transported for reabsorption. One possible explanation for the improved performance of the polymeric chelants of the present invention in binding bile acids is their ability to form hydrogen and ionic bonds with bile acids. The hydrogen bond may be formed by a secondary amine moiety of the polymer, while the ionic bond may be formed by a quaternary amine substituent. Furthermore, the external or terminal distribution of the hydrophobic portion of the polymeric chelant in relation to the backbone of the polymer and to the secondary and quaternary amine portions of the polymer contributes to a significant increase in the efficiency of each given dose of chelant. In addition, the presence of two or more hydrophobic alkyl groups as terminal substituents provides more sites for hydrophobic binding of bile salts.
The process for the preparation of the polymeric chelant of the present invention also includes several advantages. For example, alkylation of the amine moiety of a hydrocarbon amine polymer, such as a poly (allylamine) polymer, with a quaternary amine can be achieved by reacting with an amine moiety on a carbon atom-bearing leaving group that removes at least three carbon atoms from the center of the quaternary amine. In addition, it is believed that the incorporation of quaternary amines into hydrocarbon amine polymers, especially poly (allylamine) polymers, using alkylene groups having at least three carbon atoms, results in improved performance of the resulting chelants.
The use of asymmetric dihalides in the preparation of quaternary amine-containing alkylating agents of the present invention can increase the yield and purity of the desired product. Since the halogen in the asymmetric dihalide is not equivalent in reactivity, the reaction of the carbon atom bearing the more reactive halogen is almost specific, and therefore it produces a relatively pure compound in good yield. This relatively pure quaternary amine-containing alkylating agent can then be used to alkylate the amine nitrogen atoms of the hydrocarbon amine polymer backbone. Detailed description of the invention
The features and other aspects of the present invention will now be more particularly described and claimed in the appended claims. It should be understood that the specific examples, which are provided to illustrate the invention, are not limiting of the invention. The essential features of the invention can be used in a variety of situations without departing from the scope of the invention.
The term "hydrocarbon amine polymer" as used herein refers to a polymer consisting essentially of carbon, hydrogen and nitrogen. Preferred hydrocarbon amine polymers are crosslinked. More preferred hydrocarbon amine polymers are poly (allylamine) polymers. The most preferred hydrocarbon amine polymers are crosslinked poly (allylamine) polymers. Other examples of suitable hydrocarbon amine polymers include poly (vinyl amine) and poly (aziridine) polymers.
The hydrocarbon amine polymer chelants of the present invention contain a substituent attached to the amine of the polymer. The substituents include quaternary ammonium moieties wherein the nitrogen of the quaternary ammonium moiety is linked to the amine on the polymer backbone through an alkylene group having 3 or more carbon atoms. Furthermore, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having from 6 to about 24 carbon atoms, and the remaining terminal substituents are each independently an alkyl group having from 1 to about 5 carbon atoms.
The term "terminal substituent" of a quaternary amine as used herein refers to any of the three substituents on the nitrogen atom of the quaternary amine and is not the carbon chain between the amine on the polymer backbone and the amine of the quaternary ammonium center.
The term "hydrophobic alkyl" as used herein refers to an alkyl group having from 6 to about 24 carbon atoms and terminating in a hydrophobic moiety. For example, the hydrophobic alkyl group may be an aliphatic, aromatic, branched or cyclic carbon chain. The hydrophobic substituent does not include an alkylene group between a nitrogen on the amine polymer backbone and a nitrogen of the quaternary ammonium center.
In one embodiment, the hydrocarbon amine polymer is a crosslinked poly (allylamine) polymer and contains substituents attached to the amine of the polymer. The substituents include quaternary amine-containing moieties wherein the nitrogen of said quaternary amine moiety is linked to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having 6 to about 24 carbon atoms, and the remaining terminal substituents are each independently an alkyl group having 1 to about 5 carbon atoms.
Preferred examples include crosslinked poly (allylamine) polymers wherein the alkylene group is three carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Other preferred examples include crosslinked poly (allylamine) polymers wherein the alkylene group is four carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Other preferred examples include crosslinked poly (allylamine) polymers wherein the alkylene group is five carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Still other preferred examples include crosslinked poly (allylamine) polymers wherein the alkylene group is six carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
In one aspect, the poly (allylamine) polymers of the invention have the following general structure,
wherein,
n is an integer of 3 or more, and
r represents alkyl groups, at least one of which has 6 to about 24 carbon atoms and the others each having 1 to 5 carbon atoms.
A method of making a crosslinked poly (allylamine) polymer comprising reacting a crosslinked poly (allylamine) with a quaternary amine-containing compound having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
Preferred examples of cross-linked poly (allylamine) s prepared by this method include cross-linked poly (allylamine) polymers in which the alkylene group is three carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Other preferred examples of cross-linked poly (allylamine) s prepared by this method include cross-linked poly (allylamine) polymers in which the alkylene group is four carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Other preferred examples of cross-linked poly (allylamine) s prepared in this way include cross-linked poly (allylamine) polymers in which the alkylene group is five carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
Some other preferred examples of cross-linked poly (allylamine) s prepared by this method include cross-linked poly (allylamine) polymers in which the alkylene group is six carbons in length, at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group which may be octyl, decyl or dodecyl, and the remaining terminal substituents are methyl.
In another aspect, the present invention relates to hydrocarbon amine polymers containing one substituent attached to the amine of the polymer. The substituents include quaternary amine moieties wherein the nitrogen atom of said quaternary amine moiety is linked to the amine on the polymer backbone through an alkylene group of 3 or more carbon atoms, and wherein at least two or all three of the three terminal substituents of the quaternary amine are each a hydrophobic alkyl group of 6 to about 24 carbon atoms. In the case where two or three terminal substituents of the quaternary amine are each hydrophobic alkyl groups, the remaining terminal substituents are alkyl groups having from 1 to about 5 carbon atoms. In a preferred embodiment the hydrocarbon amine polymer is crosslinked.
The method of making the crosslinked hydrocarbon amine polymer of the present invention includes the step of reacting the crosslinked hydrocarbon amine polymer with a quaternary ammonium compound having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
Preferred examples of crosslinked hydrocarbon amine polymers prepared by this method include poly (vinyl amine), poly (allyl amine), and poly (aziridine) polymers.
The methods of using the poly (allylamine) polymers and hydrocarbon amine polymers of the invention include orally administering to a mammal a therapeutic amount of these polymers to bind bile acids, lower blood cholesterol, treat atherosclerosis, treat hypercholesterolemia, or lower blood lipid levels in a mammal. Typically, the therapeutic amount of hydrocarbon amine polymer and poly (allylamine) polymer is about 0.1 to about 20 grams per day.
In one aspect, the present method is a method of binding bile salts of a mammal comprising the step of orally administering to the mammal a therapeutic amount of a hydrocarbon amine polymer of the present invention. In another aspect, the present method is a method of binding bile salts of a mammal comprising the step of orally administering to the mammal a therapeutic amount of a poly (allylamine) polymer of the present invention.
In another aspect, the present method is a method of lowering blood cholesterol in a mammal comprising the step of administering to the mammal a therapeutic amount of a hydrocarbon amine polymer of the present invention, preferably a cross-linked poly (allylamine) polymer. In yet another aspect, the invention includes a method of treating atherosclerosis in a mammal comprising the step of administering to the mammal a therapeutic amount of a hydrocarbon amine polymer of the invention, preferably a cross-linked poly (allylamine) polymer. In yet another aspect, the present method is a method of treating hypercholesterolemia in a mammal comprising the step of administering to the mammal a therapeutic amount of a hydrocarbon amine polymer, preferably a crosslinked poly (allylamine) polymer, of the present invention.
Another aspect of the present invention is a method of reducing blood lipid levels in a mammal comprising orally administering to the mammal a polymer of the present invention to tightly sequester conjugated bile acids secreted by the mammal, whereby a major portion of the conjugated bile acids are excreted by the mammal, thereby accelerating lipid metabolism and thereby reducing blood lipid levels in the mammal. In a preferred example, the chelated primary bile acid includes conjugated primary bile acids, such as conjugated cholic acid and conjugated chenocholic acid.
The hydrocarbon amine polymers and poly (allylamine) polymers of the invention are particularly suitable for binding conjugated primary bile acids such as glycocholic acid and glycochenocholic acid in the body of a mammal by oral administration of the polymer. A form particularly suitable for oral administration of hydrocarbon amine polymers and poly (allylamine) polymers is one that forms a gel in the stomach of a patient.
Preferred amine polymers of the present invention can be prepared by any suitable method, examples of which are as follows:
1. one method is to prepare a homopolymer by polymerizing amine monomers. Examples of such processes include the polymerization of allylamine, aziridine, vinylamine, 1, 2-diaminoethylene, aminopropylacrylate or p-aminomethylstyrene to produce their respective homopolymers.
2. Another approach is to copolymerize the amine monomer with one or more other monomers. Such other monomers include amine monomers, such as those listed above, and non-amine monomers such as acrylamide, styrene, divinylbenzene, vinyl alcohol or vinyl chloride. Examples include copoly (allylamine/acrylamide), copoly (vinylamine/allylamine), and copoly (allylamine/divinylbenzene).
3. Another method is to polymerize non-amine monomers to produce homopolymers, which are then chemically modified to form amine polymers. Examples of such processes include the polymerization of vinyl formamide, vinyl acetamide, vinyl chloride, vinyl bromide, allyl chloride, allyl bromide, acrylamide or acrylonitrile to form their respective homopolymers. Each homopolymer is then chemically modified by hydrolysis, nucleophilic substitution or reduction to form an amine polymer. Thus, the first four homopolymers above become poly (vinylamine) and the last four become poly (allylamine). It will be appreciated that not all of the initial non-amine monomers need be chemically modified to yield amine polymers containing some initial non-amine monomers in a non-amine state.
4. A fourth method is to copolymerize the non-amine monomer with one or more other monomers. The other monomers include amine monomers, such as those listed in the first method, and non-amine monomers, such as those listed in the third method. The resulting copolymer was then chemically modified to prepare the amine polymers listed in the third method. Examples include the copolymerization of acrylamide with styrene followed by reduction to produce the copolymer (allylamine/styrene); copolymerizing acrylonitrile with vinylformamide, followed by reduction and hydrolysis reactions, to form a copoly (allylamine/vinylamine); and copolymerizing acrylonitrile with allylamine followed by reduction to form poly (allylamine). It will be appreciated that not all of the initial non-amine monomers need be chemically modified to yield amine polymers containing some initial non-amine monomers in a non-amine state.
5. A fifth method involves the preparation of amine polymers by a condensation mechanism. Examples of such processes include the reaction of diethylenetriamine with epichlorohydrin, 1, 3-dibromopropane with ethylenediamine, spermine with 1, 4-butanediol diglycidyl ether, or tris (2-aminoethyl) amine with 1, 10-dibromodecane.
Each of these amine polymers generally has a molecular weight greater than about 2,000. Examples of suitable resulting hydrocarbon amine polymers include poly (vinyl amine), poly (allyl amine), and poly (aziridine) polymers. Preferred hydrocarbon amine polymers are poly (allylamine) polymers.
Preferred hydrocarbon amine polymers are crosslinked, for example, by reacting the polymer with a suitable crosslinking agent. Examples of suitable crosslinking agents include acryloyl chloride, epichlorohydrin, butanediol glycidyl ether, ethylene glycol glycidyl ether, dimethyl succinate, and the like. Epichlorohydrin is a preferred crosslinking agent. Generally, the amount of crosslinking agent used to react with the hydrocarbon amine polymer is sufficient to allow about 0.5-20% of the sites available for reaction with the crosslinking agent to occur. In a preferred embodiment about 0.5-6% of the amine groups in the hydrocarbon amine polymer are reacted with the crosslinking agent. In another preferred embodiment about 2-12% of the amine groups in the hydrocarbon amine polymer are reacted with the crosslinking agent.
Crosslinking of the polymer can be achieved by reacting the polymer with a suitable crosslinking agent in an aqueous solution at about 25 ℃ for 18 hours to produce a colloid. The colloid is then combined with water or dried to a particulate solid. The particulate solid is then washed with water and dried under suitable conditions, such as at a temperature of about 50 ℃ for about 18 hours.
The hydrocarbon amine polymer may be alkylated to form the chelating agent of the invention. The term "alkylating agent" as used herein refers to a reagent which, when reacted with a hydrocarbon amine polymer, allows the nitrogen atom of the quaternary amine-containing moiety to be covalently linked to the main chain amine of one or more of the hydrocarbon amine polymers through an alkylene group of three or more carbon atoms. Suitable alkylating agents of the present invention may be quaternary ammonium compounds. Thus, another aspect of the invention relates toThere are quaternary amines of the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
In another aspect, X is a halide. Preferred values of n are 3-6. In another aspect, one or both of the alkyl groups is methyl.
Specific examples of quaternary ammonium compounds suitable as alkylating agents include:
(4-bromobutyl) dioctylmethylammonium bromide;
(3-bromopropyl) dodecyldimethylammonium bromide;
(3-chloropropyl) dodecyldimethylammonium bromide;
(3-bromopropyl) octyldimethylammonium bromide;
(3-chloropropyl) octyldimethylammonium bromide;
(3-iodobutyl) dioctylmethylammonium bromide;
(2, 3-epoxypropyl) decyl dimethyl ammonium bromide;
(3-chloropropyl) decyl dimethyl ammonium bromide;
(5-tosylpentyl) dodecyldimethylammonium bromide;
(6-bromohexyl) octyldimethylammonium bromide;
(12-bromododecyl) decyl dimethyl ammonium bromide;
(3-bromopropyl) tridecylammonium bromide;
(3-bromopropyl) behenyldimethylammonium bromide;
(6-bromohexyl) docosyldimethylammonium bromide;
(4-chlorobutyl) dodecyldimethylammonium bromide;
(3-chloropropyl) octadecyldimethylammonium bromide;
(3-chloropropyl) hexyldimethylammonium bromide;
(3-chloropropyl) methyldioctylammonium bromide;
(3-chloropropyl) methyldidecylammonium bromide;
(3-chloropropyl) cyclohexyldimethylammonium bromide;
(3-chloropropyl) tetradecyldimethylammonium bromide; and the like.
It will be appreciated that the above compounds may be used in halogenated form, including bromides, chlorides and iodides, as well as other negatively charged ions, such as acetates, nitrates, sulfates and p-toluenesulfonate.
Examples of one suitable method of preparing the alkylating agents, preferably quaternary ammonium compounds, of the present invention include tertiary amines having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
a step of reacting with an asymmetric dihalide having the formula,
X1--(CH2)n--X2
wherein,
X1is a chlorine-containing compound having a chlorine-containing group,
X2is bromine, and
n is an integer of 3 or more.
In another aspect, the tertiary amine may have two or all three alkyl or substituted alkyl groups having from 6 to about 24 carbon atoms. In the case of two alkyl groups, the remaining alkyl group has from 1 to about 5 carbon atoms. Typically, the alkylation reaction is carried out by combining the substituted tertiary amine with the appropriate dihalide in an organic solvent. An example of a suitable symmetric dihalide is dichloride. An example of a suitable dichloride is 1, 3-dichloropropane.
Preferred dihalides of the invention also include unsymmetrical dihalides. "asymmetric dihalide" is defined herein to mean dihalides in which the halogens are different and therefore have different reactivities as alkylating agents. Suitable examples of asymmetric dihalides include 1-bromo-3-chloropropane and 1-bromo-4-chlorobutane. In general, when the dihalide is a bromine/chlorine mixture, the terminally brominated molecule is more reactive than the terminally chlorinated molecule. Thus, an asymmetric dihalide reaction will result in a nearly exclusive reaction occurring at the bromine bearing end, while the chlorine bearing end is nearly unreactive. This relatively pure compound can then be used to alkylate the nitrogen on the hydrocarbon amine polymer by the reaction that occurs at the chlorine end. The use of an asymmetric dihalide avoids the undesirable side reactions that often occur with symmetric dihalides, both increasing the yield of alkylating agents containing quaternary amines and increasing the purity. Examples of suitable organic solvents include methanol, diethyl ether and the like. The preferred organic solvent is methanol.
The reaction is maintained at a temperature and for a time sufficient to allow the tertiary amine to react with the asymmetric dihalide. These parameters generally depend on the nature of the reactants and can be determined experimentally by one of ordinary skill in the art.
The reaction is terminated by removing the solvent by an appropriate method. The crude quaternary amine-containing alkylating agent is prepared for further reaction by methods known to those of ordinary skill in the art.
The hydrocarbon amine polymers are typically alkylated by combining the polymer with a quaternary amine-containing alkylating agent in an organic solvent or water. The amount of alkylating agent used in conjunction with the hydrocarbon amine polymer is generally sufficient to cause the alkylating agent to react with greater than about 5% of the reactive nitrogen atoms on the hydrocarbon amine polymer. Examples of suitable solvents include methanol, ethanol, acetonitrile, water, and the like. Preferred solvents are water and methanol.
It is particularly preferred in the present invention that the hydrocarbon amine polymer is a crosslinked poly (allylamine) wherein the substituent comprises (3-propyl) dodecyldimethylammonium chloride. Alternatively, the hydrocarbon amine polymer is a crosslinked poly (allylamine), wherein the substituent comprises butyl dioctylmethylammonium chloride. In addition, particularly preferred crosslinked poly (allylamine) s are crosslinked with epichlorohydrin which comprises about 0.5 to 6% of the amine in the polymer.
The hydrocarbon amine polymers of the present invention may then be treated with other materials to prepare compositions for oral administration of the hydrocarbon amine polymers.
The pharmaceutical compositions of the present invention are generally prepared by known methods using known and readily available ingredients. The hydrocarbon amine polymers may be used alone or in admixture with a carrier in the preparation of the compositions of the present invention, or diluted by a carrier, or packaged in a carrier in the form of a capsule, sachet, paper or other container. When the carrier is used as a diluent, it may be a solid, semi-solid or liquid material which acts as a carrier, excipient or medium for the polymer. Thus, the composition may be in the form of: tablets, pills, powders, lozenges, sachets, cachets, elixirs, suspensions, syrups, sols, (solid or in a liquid medium), soft or hard gelatin capsules, sterile packaged powders, and the like. Examples of suitable carriers, excipients, and diluents include foods, beverages, lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, alginates, tragacanth, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, methyl hydroxybenzoate, propyl hydroxybenzoate, and talc.
The negatively charged counterion of the pharmaceutical composition can comprise an organic ion, an inorganic ion, or a combination thereof. Inorganic ions suitable for use in the present invention include halides (especially chlorides), carbonates and bicarbonates. Suitable organic ions include acetate and benzoate salts.
The following examples further and specifically illustrate the invention. All parts and percentages are by weight unless otherwise indicated. Best mode for carrying out the invention
Example 1
Preparation of poly (allylamine) hydrochloride crosslinked with epichlorohydrin
In a 5 gallon container was added poly (allylamine) hydrochloride (1kg) from Nitto Boseki and water (4L). The mixture was stirred to dissolve the hydrochloride salt and the pH was adjusted by the addition of solid NaOH (284 g). The resulting solution was cooled to room temperature, and then the entire epichlorohydrin crosslinking agent (50mL) was added at once while stirring. The resulting mixture was gently stirred to a gum after about 35 minutes. The crosslinking reaction was continued at room temperature for 18 hours and then placed in portions into a blender with a total of 10L of water. Each batch was slowly stirred for about 3 minutes to form coarse particles and finally stirred for an additional 1 hour. The solid was collected by filtration, rinsed three times by suspending it in 10L, 15L and 20L of water, each time the suspension was stirred for 1 hour and then collected by filtration. The solid was rinsed once more suspended in isopropanol (17L), the mixture was stirred for 1 hour, and the solid was collected by filtration. The solid was dried in a vacuum oven at 50 ℃ for 18 hours to give about 677g of a particulate, brittle, white solid crosslinked polymer.
Example 2
Alkylation of crosslinked poly (allylamine) with (3-bromopropyl) dodecyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1. The flask was charged with crosslinked poly (allylamine) (12.5 g; 6% crosslinked; ground to less than 30 mesh), (3-bromopropyl) dodecyldimethylammonium bromide (17.5 g; prepared by reaction of 1, 3-dibromopropane with N, N-dimethyl-1-aminododecane in diethylether) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (1.14g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (1.14g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (1.14g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.459 mL 2M NaCl (aqueous solution)
2.459 mL 2M NaCl (aq)
3.2L deionized water
4.2L deionized water
5.2L deionized water
6.2L deionized water
The resulting solid was then dried in a 60 ℃ blast furnace (forced-air oven) to yield 17.4g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
EXAMPLE 3 alkylation of crosslinked poly (allylamine) with (3-bromopropyl) dodecyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1. The flask was charged with crosslinked poly (allylamine) (12.5 g; 6% crosslinked; ground to less than 30 mesh), (3-bromopropyl) dodecyldimethylammonium bromide (35 g; prepared by reaction of 1, 3-dibromopropane with N, N-dimethyl-1-aminododecane in diethylether) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (1.99g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (1.99g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (1.99g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.459 mL 2M NaCl (aqueous solution)
2.459 mL 2M NaCl (aq)
3.2L deionized water
4.2L deionized water
5.2L deionized water
6.2L deionized water
The resulting solid was then dried in a 60 ℃ blast furnace to give 25.6g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
Example 4
Alkylation of crosslinked poly (allylamine) with (3-bromopropyl) dodecyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1, but instead of 50mL epichlorohydrin was used, 16.7mL was used. A flask was charged with crosslinked poly (allylamine) (12.5 g; 2% crosslinked; ground to less than 30 mesh), (3-bromopropyl) dodecyldimethylammonium bromide (140.8 g; prepared by reaction of 1, 3-dibromopropane with N, N-dimethyl-1-aminododecane in diethylether) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (7.1g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (7.1g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (1.99g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.1.7L 2M NaCl (aqueous solution)
2.1.7L 2M NaCl (aqueous solution)
3.8L deionized water
4.8L deionized water
5.8L deionized water
6.8L deionized water
7.4L deionized water
The resulting solid was then dried in a 60 ℃ blast furnace to give 39.8g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
Example 5
Alkylation of crosslinked poly (allylamine) with (3-bromopropyl) dodecyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1. The flask was charged with crosslinked poly (allylamine) (12.5 g; 6% crosslinked; ground to less than 30 mesh), (3-bromopropyl) dodecyldimethylammonium bromide (30.2 g; prepared by reaction of 1, 3-dibromopropane with N, N-dimethyl-1-aminododecane in diethylether) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (2.0g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (2.0g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (2.0g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.800 mL 2M NaCl (aqueous solution)
2.800 mL 2M NaCl (aqueous solution)
3.2L deionized water
4.2L deionized water
5.1L deionized water
The resulting solid was then dried in a 60 ℃ blast furnace to give 16.8g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
Example 6
Alkylation of crosslinked poly (allylamine) with (6-bromohexyl) octyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1. The flask was charged with crosslinked poly (allylamine) (12.5 g; 6% crosslinked; ground to less than 30 mesh), (6-bromohexyl) octyldimethylammonium bromide (33.7 g; prepared by reaction of 1, 6-dibromohexane with N, N-dimethyl-1-aminooctane in diethyl ether) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (1.68g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (1.68g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (1.68g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.1L 2M NaCl (aqueous solution)
2.1L 2M NaCl (aqueous solution)
3. Repeating 1L of deionized water until the conductivity of the solution is less than 1mS/cm
The resulting solid was then dried in a 60 ℃ blast furnace to give.15.7 g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
Example 7
Alkylation of crosslinked poly (allylamine) with (4-butyl) dioctylmethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1, but using 25mL instead of 50mL of epichlorohydrin crosslinker. A flask was charged with crosslinked poly (allylamine) (12.5 g; 3% crosslinked; ground to less than 30 mesh), (4-bromobutyl) dioctylmethylammonium bromide (65.8g crude; prepared by reaction of 1, 4-dibromobutane with N, N-dioctylmethylamine in methanol) and methanol (334 mL). The mixture was heated to 65 ℃ while stirring, an aqueous sodium hydroxide solution (3.28g of a 50% solution) was added thereto when 65 ℃ was reached, and stirring was continued at 65 ℃ for 2 hours. Aqueous sodium hydroxide solution (3.28g of 50% solution) was added twice in succession, each time with continuous stirring at 65 ℃ for 2 hours. An additional aqueous sodium hydroxide solution (3.28g of 50% solution) was added and stirring was continued at 65 ℃ for 12 hours. The mixture was then cooled to room temperature.
The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.800 mL of methanol
2.1000 mL of methanol
3.890 mL 2M NaCl (aq)
4.890 mL 2M NaCl (aq)
5.2L deionized water
6.2L deionized water
The resulting solid was then dried in a 60 ℃ blast furnace to give 27.1g of an off-white solid. The solids were ground and screened through a 80 mesh screen.
Example 8
Preparation of (3-chloropropyl) dodecyl diethyl ammonium bromide
Into a 2L three necked round bottom flask equipped with an air condenser and magnetic stirrer was charged N, N-dimethyldodecylamine (297.24g, 1.40mol), 1-bromo-3-chloropropane (220.44g, 1.40mol) and methanol (250 mL). The reaction was maintained at 65 ℃ for 24 hours. Methanol was removed by rotary evaporation under reduced pressure to give a brown precipitate. Methyl-t-butyl ether (2L) was added to the sediment to yield a white solid. The mixture was stirred for 2 hours and the resulting semi-crystalline white particles were collected by vacuum filtration. These particles were dried in a vacuum oven at 35 ℃ for 24 hours to give 228.2g (0.61mol, 44%) of the title compound.
Example 9
Alkylation of crosslinked poly (allylamine) with (3-chloropropyl) dodecyldimethylammonium bromide
Crosslinked poly (allylamine) was prepared as described in example 1, except that the final crosslinking was 3 mole%. In a 2L three-necked flask equipped with a thermometer and condenser were placed crosslinked poly (allylamine) (25 g; 3% crosslinked; ground to 10 mesh), (3-chloropropyl) dodecyldimethylammonium bromide (280g, 0.755 mol; prepared as described in example 8) and water (750 mL). The mixture was heated to 100 ℃ while stirring, and after reaching 100 ℃ 10 aqueous sodium hydroxide solution (6.1g of 50% solution) was added at regular intervals over 8 hours. Stirring was continued at 100 ℃ for 16 hours. The mixture was then cooled to room temperature.
Concentrated hydrochloric acid (50mL) was added and the mixture was stirred for 10 minutes, then filtered to collect the solid. The solid was rinsed on the funnel with 1.5L of methanol. The solid product was filtered off and washed with the suspension while stirring for 30 minutes, and filtered from the following liquid:
1.1L of methanol
2.3.3L 2M NaCl (aqueous solution)
3.3.3L 2M NaCl (aqueous solution)
4.3.3L 2M NaCl (aqueous solution)
5.8L deionized water
The solid was resuspended in deionized water (4L) and the pH adjusted to 2.2 with HCl. The solid (178.6g) was collected by filtration and then dried in a blast furnace at 60 ℃ to give 111g of a solid. The solids were ground and screened through a 80 mesh screen.
Example 10
Alkylation of crosslinked poly (allylamine) with (3-chloro) propyl-dimethylhexylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (3-chloro) propyl-dimethylhexylammonium bromide (216.4g), to give 85.6g of product.
Example 11
Alkylation of crosslinked poly (allylamine) with (3-propyl) dimethylcyclohexylammonium bromide
Example 9 was repeated, using (3-chloropropyl) dimethylcyclohexylammonium bromide (213.2g) in place of (3-chloropropyl) dodecyldimethylammonium bromide to give 86.4g of product.
Example 12
Alkylation of crosslinked poly (allylamine) with (3-chloropropyl) dimethyloctylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (3-chloropropyl) dimethyloctylammonium bromide (237.7g), to give 104.6g of product.
Example 13
Alkylation of crosslinked poly (allylamine) with (3-chloropropyl) dimethyldecylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (3-chloropropyl) dimethyldecylammonium bromide (269.4g), to give 101.7g of product.
Example 14
Alkylation of crosslinked poly (allylamine) with (3-chloropropyl) dimethyltetradecylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (3-chloropropyl) dimethyltetradecylammonium bromide (301.2g) to give 112.3g of product.
Example 15
Alkylation of crosslinked poly (allylamine) with (3-chloropropyl) methyldioctylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (3-chloropropyl) methyldioctylammonium bromide (272g) and adding 5.5g of aqueous NaOH solution each time, to give 96.8g of product.
Example 16
Alkylation of crosslinked poly (allylamine) with (4-chlorobutyl) methyldioctylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (4-chlorobutyl) methyldioctylammonium bromide (241.6g) and adding 4.4g of aqueous NaOH each time, to give 80.0g of product.
Example 17
Alkylation of crosslinked poly (allylamine) with (4-chlorobutyl) dimethyldodecylammonium bromide
Example 9 was repeated, using (4-chlorobutyl) dimethyldodecylammonium bromide (290.5g) in place of (3-chloropropyl) dodecyldimethylammonium bromide to give 93.9g of product.
Example 18
Alkylation of crosslinked poly (allylamine) with (5-chloropentyl) methyldodecylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (5-chloropentyl) methyldodecylammonium bromide (150.6g) and adding 3.0g of aqueous NaOH solution each time to give 46.2g of product.
Example 19
Alkylation of crosslinked poly (allylamine) with (10-bromodecyl) trimethylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (10-bromodecyl) trimethylammonium bromide (271.0 g). Water (100mL) was added after 4 hours and water (100mL) was added after 8 hours to give 101.8g of product.
EXAMPLE 20 alkylation of crosslinked poly (allylamine) with (6-chlorohexyl) dimethyldecylammonium bromide
Example 9 was repeated, replacing (3-chloropropyl) dodecyldimethylammonium bromide with (6-chlorohexyl) dimethyldecylammonium bromide (145.2g) and adding 3.0g of aqueous NaOH each time, to give 46.2g of product.
Example 21
Preparation of (4-chlorobutyl) dimethyldodecylammonium bromide
Into a 1000mL round bottom flask equipped with an air condenser and magnetic stirrer were added N, N-dimethyldodecylamine (308.8g, 1.45mol), 1-bromo-4-chlorobutane (249.98g, 1.45mol) and 300mL of methanol. The reaction was held at 65 ℃ for 48 hours. The solvent was removed by rotary evaporation under reduced pressure to give a brown oil. To this oil was added 100mL of butanol. The mixture was distilled under vacuum at 30-50 ℃ until the distillate ceased to collect, yielding 384.47g (0.99mol, 69%) of the title compound.
Example 22
Preparation of (2-chloroethyl) dimethyldodecylammonium bromide
A1000 mL round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethyldodecylamine (186.46g, 0.875mol), 1-bromo-2-chloroethane (125.60g, 0.875mol) and methanol (150 mL). The reaction was held at 65 ℃ for 48 hours. The solvent was removed by rotary evaporation under reduced pressure to give a brown oil. The oil was stirred in a beaker with t-butyl methyl ether (2L) to form a brownish white precipitate. The solid was collected by vacuum filtration. The solid was dried in a vacuum oven at 30 ℃ overnight to give 197.0g (0.55mol, 63%) of the title compound.
Example 23
Comparison of reactivity towards Quaternary ammonium alkylating Agents
Alkylating agents (4-chlorobutyl) dodecyldimethylammonium bromide, (3-chloropropyl) dodecyldimethylammonium bromide and (2-chloroethyl) dodecyldimethylammonium bromide were prepared as described in examples 21, 8 and 22, respectively. Each alkylating agent was separately reacted with the poly (allylamine) prepared in example 9 under the same conditions. The reactivity of each alkylating agent with the amine of the poly (allylamine) backbone was evaluated and compared to give the following results:
alkylating agents | Starting polymers | Alkylated polymers | Alkylation (%) |
(4-chlorobutyl) dodeca dimethyl ammonium bromide n ═ 4 | 25g | 94g | 109 |
(3-chloropropyl) dodecyl dimethyl ammonium bromide n ═ 3 | 25g | 111g | 124 |
(2-chloroethyl) dodecyl dimethyl ammonium bromide n ═ 2 | 25g | 28g | 15 |
Elemental analysis was used to obtain the percent alkylation. One-fold alkylation for each amine corresponds to 100% alkylation; twice as much alkylation for each amine corresponds to 200% alkylation; three-fold alkylation for each amine corresponds to 300% alkylation. The N/C ratio of the polymer was obtained from elemental analysis. Since the alkylating agent has a different N/C ratio than the base polymer, it can be directly determined how much of a given alkylating agent must be bound to the polymer to improve the N/C ratio of the starting materials and the final product. This result is expressed as the percentage of the total amines of the polymer that have been alkylated, a number greater than 100% indicating that a single amine is multiply alkylated. For example, the N/C ratio of the starting material is 0.313, and after alkylation with an alkylating agent having N-3, the N/C ratio becomes 0.0922, indicating 124% alkylation. The calculation formula is as follows:
percent alkylation ═ 3.2*(N/C)-1)/(1-N/C*17) Where 3.2 is the C/N ratio of the starting material and 17 is the C/N ratio of the alkylating agent (for alkylating agents where N is 2 and 4, the values are 16 and 18, respectively).
From these results, it is clear that the alkylating agent of n-2 is much less effective in alkylating the amine of an amine polymer than the alkylating agents of n-3 and n-4. We hypothesize that this effect is due to the influence of the quaternary amine on the reactivity of the alkyl halide. It can therefore be concluded that the use of alkylating agents in which the quaternary amine is greater than 2 carbon atoms removed from the carbon atoms of the halogen-bearing alkyl halide leads to unexpected improvements in alkylating agents having less than 2 carbon atoms.
Example 24
Preparation of (3-chloropropyl) cyclohexyl dimethyl ammonium bromide
Into a 1L three-necked Morton flask equipped with an air condenser and a magnetic stirrer were charged N, N-dimethylcyclohexylamine (210.46g, 1.65mol), 1-bromo-3-chloropropane (259.99g, 1.65mol) and methanol (250 mL). The reaction was maintained at 65 ℃ for 24 hours. Methanol was removed by rotary evaporation under reduced pressure to give a brown precipitate. To the sediment was added tert-butyl methyl ether (600mL) to form an oil. The liquid was decanted from the oil and a second batch of methyl tertiary butyl ether (600mL) was added. The mixture was stirred and the liquid decanted from the thick sediment. Diethyl ether (600mL) was added to the sediment to form a white semi-solid layer. The mixture was stirred and the liquid was removed. The white solid was placed in a vacuum oven at 35 ℃ for 24 hours to give 404.9g (1.42mol, 85%) of the title compound.
Example 25
Preparation of (3-chloropropyl) tetradecyldimethylammonium bromide
N, N-dimethyltetradecylamine (311.59g, 1.29mol), 1-bromo-3-chloropropane (203.09g, 1.29mol) and methanol (250mL) were charged in a 1L three-necked round-bottomed flask equipped with an air condenser and a magnetic stirrer. The reaction was maintained at 65 ℃ for 24 hours. Methanol was removed by rotary evaporation under reduced pressure to give a precipitate. To the residue was added methyl tert-butyl ether (500mL) to slowly form a white solid. The mixture was stirred for 1.5 hours and a white paste-like mass was collected by vacuum filtration. The solid was placed in a vacuum oven at 35 ℃ for 24 hours to yield 420g (1.05mol, 82%) of the title compound.
Example 26
Preparation of (3-chloropropyl) hexyldimethylammonium bromide
A500 mL three necked round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethylhexylamine (199.46g, 1.54mol), 1-bromo-3-chloropropane (243.00g, 1.54mol) and methanol (250 mL). The reaction was maintained at 65 ℃ for 24 hours. The solvent was removed by rotary evaporation under reduced pressure to give 445.8g (1.55mol, 100%) of a brown viscous oil.
Example 27
Preparation of (3-chloropropyl) octyl dimethyl ammonium bromide
A500 mL three-necked round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethyloctylamine (110.02g, 0.70mol), 1-bromo-3-chloropropane (110.2g, 0.70mol) and methanol (150 mL). The reaction was maintained at 65 ℃ for 24 hours. The solvent was removed by rotary evaporation under reduced pressure to give a brown oil. The oil was extracted by mixing with methyl-tert-butyl ether (600mL) in a large crusher and the excess solvent was decanted. This was repeated 3 times. Finally, the oil was extracted with diethyl ether (600mL) and excess solvent was decanted off. The viscous oil was dried overnight in a vacuum oven at 35 deg.C to yield 174.14g (0.55mol, 79%) of the title compound.
Example 28
Preparation of (3-chloropropyl) octadecyl dimethyl ammonium bromide
A1000 mL round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethyloctadecylamine (301.0g, 1.01mol), 1-bromo-3-chloropropane (170.0g, 1.08mol) and methanol (200 mL). The reaction was held at 65 ℃ for 18 hours. The solvent was removed by rotary evaporation under reduced pressure to give a clear oil. After the oil was poured into a beaker filled with methyl ethyl ketone (250mL), a white precipitate formed. The solid was collected by vacuum filtration and then resuspended in methyl ethyl ketone (250 mL). This was repeated twice and finally the solid was collected in vacuo. The solid was placed in a vacuum oven at 30 ℃ overnight to yield 274.9g (0.59mol, 58%) of the title compound.
Example 29
Preparation of (3-chloropropyl) decyl dimethyl ammonium bromide
A1000 mL round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethyldecylamine (200.0g, 1.08mol), 1-bromo-3-chloropropane (170g, 1.08mol) and methanol (200 mL). The reaction was held at 65 ℃ for 18 hours. The solvent was removed by rotary evaporation under reduced pressure and distilled under high vacuum to give a brown oil. The oil was placed in a beaker and stirred with a 1: 1 solution of hexane/tert-butyl methyl ether (400mL) to form a white precipitate. The solid was collected by vacuum filtration and dried in a vacuum oven at 30 ℃ overnight to yield 305.0g (0.089mol, 82%) of the title compound.
Example 30
Preparation of (3-chloropropyl) dioctylmethylammonium bromide
Into a 1L three necked round bottom flask equipped with an air condenser and magnetic stirrer was charged N, N-dioctylmethylamine (202.48g, 0.79mol), 1-bromo-3-chloropropane (124.8g, 0.79mol) and methanol (250 mL). The reaction was maintained at 65 ℃ for 2 days. Methanol was removed by rotary evaporation under reduced pressure to give an oil. To the oil were added methyl ethyl ketone (50mL) and hexane (200mL) to slowly form a white solid. The solvent was decanted from the mixture. The remaining solid was washed twice with hexane (50 mL). The solid was placed in a vacuum oven at 35 ℃ for 24 hours to give 259g (0.625mol, 79%) of a waxy solid.
Example 31
Preparation of (3-chloropropyl) didecylmethylammonium bromide
Into a 2L three necked round bottom flask equipped with an air condenser and magnetic stirrer was charged N, N-didecylmethylamine (65.49g, 0.21mol), 1-bromo-3-chloropropane (33.06g, 0.21mol) and methanol (250 mL). The reaction was maintained at 65 ℃ for 6 days. Methanol was removed by rotary evaporation under reduced pressure to give an oil. Hexane (200mL) was added to the oil and a white solid was slowly formed. The solvent was decanted from the mixture. The remaining solid was dried under vacuum overnight to yield 81.67g (0.17mol, 82%) of the title compound.
Example 32
Preparation of (6-chlorohexyl) dodecadimethyl ammonium bromide
Into a 500mL round bottom flask equipped with an air condenser and magnetic stirrer was charged N, N-dioctylmethylamine (95.13g, 0.513mol), 1-bromo-3-chloropropane (102.40g, 0.513mol) and tert-butyl methyl ether (200 mL). The reaction was held at 58 ℃ for 14 hours during which time a white precipitate formed. The reaction was cooled to room temperature and tert-butyl methyl ether (350mL) was added. The solid was collected by vacuum filtration. The mother liquor was allowed to continue the reaction at 60 ℃ and the solid was collected in a similar manner. The solids obtained in both times were combined and dried in a vacuum oven at 35 ℃ for 24 hours to give 127.36g of the title compound.
Example 33
Preparation of (4-chlorobutyl) dioctylmethylammonium bromide
A500 mL round bottom flask equipped with an air condenser and magnetic stirrer was charged with N-methyldioctylamine (201.83g, 0.790mol), 1-bromo-4-chlorobutane (135.517g, 0.790mol) and methanol (250 mL). The reaction was held at 68 ℃ for 48 hours. The reaction was cooled to room temperature and the solvent was removed by rotary evaporation until a viscous oil was obtained. Removal of the solvent at 50 ℃ under high vacuum was continued to give 333.53g of a thick brown oil.
Example 34
Preparation of (5-chloropentyl) dodecamethylammonium bromide
A500 mL round bottom flask equipped with an air condenser and magnetic stirrer was charged with N, N-dimethyldodecylamine (230.17g, 1.078mol), 1-bromo-5-chloropentane (199.77g, 1.076mol) and tert-butyl methyl ether (250 mL). The reaction became a white viscous with a precipitate after heating at 60 ℃ for 2 hours. Additional tert-butyl methyl ether (250mL) was added. The reaction was held at 60 ℃ for 24 hours. The reaction was cooled to room temperature and the solid collected by vacuum filtration. The solid was dried in a vacuum oven at 35 ℃ for 24 hours to give 207.40g of the title compound.
Example 35
Preparation of crosslinked poly (vinylamine); with (3-chloropropyl) dimethyl
Dodecylammonium bromide alkylated cross-linked poly (vinylamine)
Poly (vinylamine) free base (mw 40,000; product of Air Products; 62.5g) was dissolved in water (188mL) and methanol (250 mL). Epichlorohydrin (2.8g) was added and the mixture was stirred until a gum was formed. The gum was dissolved and suspended in water (13L). The solid was collected by filtration and dried in a 60 ℃ blast furnace to give 75.2g of a solid. The solid was ground and sieved through a 10 mesh sieve.
The ground solid (14.8g) was reacted in a similar manner to example 9 using 140g of (3-chloropropyl) dimethyldodecylammonium bromide and 30g of aqueous base to give 57.7g of product. Comparison of efficiencies for examples 10, 12, 13 and 19
Examples 10, 12, 13 and 19 were made with alkylating agents of the form:wherein,
examples | n | m | Longest hydrophobic alkyl group | All carbon atoms |
10121319 | 33310 | 68100 | 681010 | 11131513 |
Examples 10, 12 and 13 are examples of the present invention containing a terminal hydrophobic alkyl group. The chain length of the hydrophobic alkyl group is 6 in example 10 and 8 and 10 in examples 12 and 13, respectively. But the hydrocarbon chain with one end attached to the quaternary amine and the other end attached to the amine on the polymer backbone (n-10) in example 19 was not considered as the terminal hydrophobic group.
These examples are considered to be a proper comparison of the difference in efficiency of the non-or terminal hydrophobic groups of the alkylating agent with those inside the alkylating agent, and the difference between the quaternary amine and the amine polymer. Comparative example 19 (example of hydrophobe between quaternary amine and amine polymer) these examples were selected to have the same total number of carbon atoms (example 12), or the same individual hydrophobe length (example 13), or the same number of carbon atoms in the unbranched segments (11; example 10). In addition, the amount of alkylating agent attached to the polymer backbone in these polymers is similar based on the yield of the alkylation reaction.
In vivo tests of the chelators prepared in examples 10, 12, 13 and 19 were performed on rats. Animals were injected subcutaneously with bile acids (cholic acid and chenocholic acid) labeled with 14C solution. The labeled bile acid is present in the same ratio as in gall bladder bile (3: 1; cholic acid: chenocholic acid). They enter the gallbladder and interact with the animal's own bile. The animals were then fed the drug-containing feed for 36 hours and feces were collected over the last 29 hours. Fecal samples were processed and radioactivity was counted. The results are expressed as the percentage or ratio of radiolabeled excreta to those of animals not fed the chelator.
EXAMPLES Activity*
10 184%
12 200%
13 184%
19 143%
Percentage of radioactivity excreted per gram of feces relative to control without chelator.
These data demonstrate that for chelants with equivalent "hydrophobe" chain lengths, chelants with hydrophobic alkyl groups at the end have a significant advantage over chelants with hydrophobic alkyl groups on the inside. Equivalents of the same
Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described specifically herein. Such equivalents are intended to be encompassed by the scope of the following claims.
Claims (68)
1. A crosslinked poly (allylamine) polymer comprising an amine substituent attached to said polymer, said substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having 6 to about 24 carbon atoms and the remaining terminal substituents are each an alkyl group having 1 to about 5 carbon atoms.
2. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 3 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
3. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 3 carbon atoms, the hydrophobic alkyl group is a decyl group, and the remaining terminal substituents are methyl groups.
4. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 3 carbon atoms, hydrophobic alkyl is dodecyl, and the remaining terminal substituents are methyl.
5. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 4 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
6. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 4 carbon atoms, the hydrophobic alkyl group is a decyl group, and the remaining terminal substituents are methyl groups.
7. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 4 carbon atoms, the hydrophobic alkyl group is a dodecyl group, and the remaining terminal substituents are methyl groups.
8. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 5 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
9. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 5 carbon atoms, the hydrophobic alkyl group is a decyl group, and the remaining terminal substituents are methyl groups.
10. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 5 carbon atoms, the hydrophobic alkyl group is a dodecyl group, and the remaining terminal substituents are methyl groups.
11. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 6 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
12. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 6 carbon atoms, the hydrophobic alkyl group is a decyl group, and the remaining terminal substituents are methyl groups.
13. The crosslinked poly (allylamine) polymer of claim 1, wherein the alkylene has 6 carbon atoms, the hydrophobic alkyl group is a dodecyl group, and the remaining terminal substituents are methyl groups.
14. The crosslinked poly (allylamine) polymers are prepared by a process comprising reacting a crosslinked poly (allylamine) with a quaternary amine-containing compound having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
15. The crosslinked poly (allylamine) polymer of claim 14, wherein n is from 3 to about 6.
16. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 3, at least one alkyl group is an octyl group, and the remaining alkyl groups are methyl groups.
17. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 3, at least one alkyl group is a decyl group, and the remaining alkyl groups are methyl groups.
18. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 3, at least one alkyl group is dodecyl, and the remaining alkyl groups are methyl.
19. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 4, at least one alkyl group is an octyl group, and the remaining alkyl groups are methyl groups.
20. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 4, at least one alkyl group is a decyl group, and the remaining alkyl groups are methyl groups.
21. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 4, at least one alkyl group is dodecyl, and the remaining alkyl groups are methyl.
22. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 5, at least one alkyl group is an octyl group, and the remaining alkyl groups are methyl groups.
23. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 5, at least one alkyl group is a decyl group, and the remaining alkyl groups are methyl groups.
24. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 5, at least one alkyl group is dodecyl, and the remaining alkyl groups are methyl.
25. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 6, at least one alkyl group is an octyl group, and the remaining alkyl groups are methyl groups.
26. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 6, at least one alkyl group is a decyl group, and the remaining alkyl groups are methyl groups.
27. The crosslinked poly (allylamine) polymer of claim 15, wherein n is 6, at least one alkyl group is dodecyl, and the remaining alkyl groups are methyl.
28. A hydrocarbyl amine polymer comprising an amine substituent attached to said polymer, the substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least two of the three terminal substituents of the quaternary amine are hydrophobic alkyl groups having 6 to about 24 carbon atoms and the other terminal substituent is an alkyl group having 1 to about 5 carbon atoms.
29. The hydrocarbon amine polymer of claim 28, wherein the polymer is crosslinked.
30. A hydrocarbon amine polymer comprising an amine substituent attached to said polymer, said substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group of 3 or more carbon atoms, and wherein the three terminal substituents of the quaternary amine are hydrophobic alkyl groups of 6 to about 24 carbon atoms.
31. The hydrocarbon amine polymer of claim 30 where the polymer is crosslinked.
32. A crosslinked hydrocarbon amine polymer prepared by a process comprising reacting a crosslinked hydrocarbon amine polymer with a quaternary amine-containing compound having the formula,
wherein,
r represents alkyl, at least one of which has 6 to about 24 carbon atoms and the remainder each having 1 to 5 carbon atoms,
n is an integer of 3 or more,
x is a leaving group, and
y is a negatively charged counterion.
33. The crosslinked hydrocarbon amine polymer of claim 32, wherein the polymer is a poly (vinylamine) polymer.
34. The crosslinked hydrocarbon amine polymer of claim 32, wherein the polymer is a poly (allylamine) polymer.
35. The crosslinked hydrocarbon amine polymer of claim 32, wherein the polymer is a poly (aziridine) polymer.
36. A method of binding bile salts in a mammal comprising orally administering to the mammal a therapeutic amount of a cross-linked poly (allylamine) polymer having an amine substituent group attached to said polymer, the substituent group comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having from 6 to about 24 carbon atoms and the remaining terminal substituents are each independently an alkyl group having from 1 to about 5 carbon atoms.
37. A method of binding bile salts of a mammal comprising orally administering to the mammal a therapeutic amount of a hydrocarbon amine polymer comprising an amine substituent group attached to said polymer, said substituent group comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms and wherein at least two of the three terminal substituents of the quaternary amine are hydrophobic alkyl groups having from 6 to about 24 carbon atoms and the other terminal substituent is an alkyl group having from 1 to about 5 carbon atoms.
38. A method of lowering blood cholesterol in a mammal comprising orally administering to the mammal a therapeutic amount of a cross-linked poly (allylamine) polymer having an amine substituent attached to said polymer, the substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group of 3 or more carbon atoms and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group of 6 to about 24 carbon atoms and the remaining terminal substituents are each independently an alkyl group of 1 to about 5 carbon atoms.
39. A method of treating atherosclerosis in a mammal comprising orally administering to the mammal a therapeutic amount of a cross-linked poly (allylamine) polymer having an amine substituent group attached to said polymer, said substituent group comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having 6 to about 24 carbon atoms and the remaining terminal substituents are each independently an alkyl group having 1 to about 5 carbon atoms.
40. A method of treating hypercholesterolemia in a mammal comprising orally administering to the mammal a therapeutic amount of a cross-linked poly (allylamine) polymer having an amine substituent attached to said polymer, the substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group of 3 or more carbon atoms and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group of 6 to about 24 carbon atoms and the remaining terminal substituents are each independently an alkyl group of 1 to about 5 carbon atoms.
41. A method of lowering blood lipid levels in a mammal comprising orally administering to the mammal a therapeutic amount of a cross-linked poly (allylamine) polymer having an amine substituent group attached to said polymer, said substituent group comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group having 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group having from 6 to about 24 carbon atoms and the remaining terminal substituents are each independently an alkyl group having from 1 to about 5 carbon atoms.
43. The compound of claim 42, wherein one or both of said alkyl groups is methyl.
44. The compound of claim 43, wherein n is from 3 to about 8.
45. The compound of claim 44, wherein X is halide.
47. The compound of claim 46, wherein one alkyl is methyl.
48. The compound of claim 47, wherein n is from 3 to about 8.
49. The compound of claim 48, wherein X is halide.
51. The compound of claim 50, wherein n is from 3 to about 8.
52. The compound of claim 51, wherein X is halide.
comprising reacting a tertiary amine of the formula
Wherein,
r represents an alkyl group, at least one of which has 6 to about 24 carbon atoms, the remainder
Each having from 1 to 5 carbon atoms,
reacting with an asymmetric dihalide of the formula,
X1--(CH2)n--X2
wherein,
X1is a chlorine-containing compound having a chlorine-containing group,
X2is bromine, and
n is an integer of 3 or more.
Wherein,
r represents an alkyl group, at least two of which have from 6 to about 24 carbon atoms, the remainder
One having from 1 to 5 carbon atoms and one having from 1 to 5 carbon atoms,
reacting with an asymmetric dihalide of the formula,
X1--(CH2)n--X2
wherein
X1Is a chlorine-containing compound having a chlorine-containing group,
X2is bromine, and
n is an integer of 3 or more.
comprising reacting a tertiary amine of the formulaWherein,
r represents an alkyl group, all three of which each have from 6 to about 24 carbon atoms, with an asymmetric dihalide of the formula,
X1--(CH2)n--X2wherein,
X1is a chlorine-containing compound having a chlorine-containing group,
X2is bromine, and
n is an integer of 3 or more.
56. A poly (allylamine) polymer comprising an amine substituent attached to said polymer, the substituent comprising a quaternary amine-containing moiety wherein the nitrogen atom of said quaternary amine moiety is attached to the amine of the polymer through an alkylene group of 3 or more carbon atoms, and wherein at least one of the three terminal substituents of the quaternary amine is a hydrophobic alkyl group of 6 to about 24 carbon atoms, and the remaining terminal substituents are each independently an alkyl group of 1 to about 5 carbon atoms.
57. The poly (allylamine) polymer of claim 56, wherein the alkylene has 3 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
58. The poly (allylamine) polymer of claim 56, wherein the alkylene has 3 carbon atoms, hydrophobic alkyl is decyl, and the remaining terminal substituents are methyl.
59. The poly (allylamine) polymer of claim 56, wherein the alkylene has 3 carbon atoms, hydrophobic alkyl is dodecyl, and the remaining terminal substituents are methyl.
60. The poly (allylamine) polymer of claim 56, wherein the alkylene has 4 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
61. The poly (allylamine) polymer of claim 56, wherein the alkylene has 4 carbon atoms, hydrophobic alkyl is decyl, and the remaining terminal substituents are methyl.
62. The poly (allylamine) polymer of claim 56, wherein the alkylene has 4 carbon atoms, hydrophobic alkyl is dodecyl, and the remaining terminal substituents are methyl.
63. The poly (allylamine) polymer of claim 56, wherein the alkylene has 5 carbon atoms, the hydrophobic alkyl group is octyl, and the remaining terminal substituents are methyl.
64. The poly (allylamine) polymer of claim 56, wherein the alkylene has 5 carbon atoms, hydrophobic alkyl is decyl, and the remaining terminal substituents are methyl.
65. The poly (allylamine) polymer of claim 56, wherein the alkylene has 5 carbon atoms, hydrophobic alkyl is dodecyl, and the remaining terminal substituents are methyl.
66. The poly (allylamine) polymer of claim 56, wherein the alkylene has 6 carbon atoms, the hydrophobic alkyl is octyl, and the remaining terminal substituents are methyl.
67. The poly (allylamine) polymer of claim 56, wherein the alkylene has 6 carbon atoms, hydrophobic alkyl is decyl, and the remaining terminal substituents are methyl.
68. The poly (allylamine) polymer of claim 56, wherein the alkylene has 6 carbon atoms, hydrophobic alkyl is dodecyl, and the remaining terminal substituents are methyl.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96194613A CN1189168A (en) | 1995-06-06 | 1996-06-06 | Hydrophobic heteroatom-containing sequestrant for cholesterol depletion |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/469,659 | 1995-06-06 | ||
CN96194613A CN1189168A (en) | 1995-06-06 | 1996-06-06 | Hydrophobic heteroatom-containing sequestrant for cholesterol depletion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1189168A true CN1189168A (en) | 1998-07-29 |
Family
ID=5128740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96194613A Pending CN1189168A (en) | 1995-06-06 | 1996-06-06 | Hydrophobic heteroatom-containing sequestrant for cholesterol depletion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1189168A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102858347A (en) * | 2010-02-24 | 2013-01-02 | 瑞立普萨公司 | Polyimidazoles for use as bile acid sequestrants |
CN110396149A (en) * | 2014-02-11 | 2019-11-01 | 塞特工业公司 | As the useful polymer containing primary amine of scale inhibitor |
-
1996
- 1996-06-06 CN CN96194613A patent/CN1189168A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102858347A (en) * | 2010-02-24 | 2013-01-02 | 瑞立普萨公司 | Polyimidazoles for use as bile acid sequestrants |
GB2490853B (en) * | 2010-02-24 | 2018-08-08 | Relypsa Inc | Polyimidazoles for use as bile acid sequestrants |
CN110396149A (en) * | 2014-02-11 | 2019-11-01 | 塞特工业公司 | As the useful polymer containing primary amine of scale inhibitor |
CN110396149B (en) * | 2014-02-11 | 2023-09-05 | 塞特工业公司 | Primary amine-containing polymers useful as scale inhibitors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1136855C (en) | Cross-linked polymers for removing bile salts from patient | |
CN1087317C (en) | Block polymer having functional groups at both ends | |
CN1270524A (en) | Cationic polymers as toxin-binding agents | |
CN1114633C (en) | Novel surfactant copolymers based on 1,1-methylene malonate | |
CN1374875A (en) | Heterobifunctional poly(ethylene Glycol) derivatives and methods for their preparation | |
CN1149228C (en) | Emulsion polymerization under existence of one stable free radical | |
CN1224637C (en) | Method for producing water-in-water polymer displersions | |
CN1145661C (en) | Biodegradable and thermosensitive polyphosphazenes and their prepn. method | |
CN1103871A (en) | Bile acid sequestrant | |
CN1829763A (en) | Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same | |
CN1151117A (en) | Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) | |
CN1494946A (en) | Bimetallic cyanide catalyst for preparing polybasic alcohol and its related method | |
CN1133642C (en) | Nucleoside 5'-thiophosphoryl amino-acid ester compound | |
CN1211993A (en) | Branched polymer synthesis | |
CN1056056A (en) | The compositions and the control method thereof of control cholesterol | |
CN1100434A (en) | Hydrophobic dispersants used in forming polymer dispersions | |
CN1735633A (en) | LCST polymers | |
CN1066661A (en) | Show superior resistance to organic bases, based on the fluoroelastomer of vinylidene fluoride | |
CN1084524A (en) | The polymkeric substance that contains the oleophylic side group of biodegradable fracture | |
CN1727369A (en) | Fluoroelastomers | |
CN1147823A (en) | A process for making a high nitrile multipolymer prepared from acrylonitrile and olefinically unsaturated monomers | |
CN87100911A (en) | Preparation contains the method for the polymkeric substance of alkoxylate/cation-modified acid amides | |
CN1659134A (en) | Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom | |
CN1189168A (en) | Hydrophobic heteroatom-containing sequestrant for cholesterol depletion | |
CN1976940A (en) | Novel supported phosphazene catalysts, novel compounds for the catalysts, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1009820 Country of ref document: HK |